Focusing on the research and development of generic and innovative drugs, Qilu Pharmaceutical has formed a complete innovative development system covering early stage discovery, development and commercialization of chemical and biologic drugs with five major R&D centers based in China and US as the innovation source. The research team, comprised of over 3,500 members, fully utilizes the innovative drug R & D center technology with global independent intellectual property right (IPR), targeting at the tumor and autoimmune diseases, the team has initiated over 60 new “First-in-Class” drug projects.
Relying on strong scientific research and innovation capabilities, Qilu Pharmaceutical has launched over 300 products on the market, among which over 55 were “First-to-Launch” in China, together with over 200 products in the pipeline. In the past one decade, Qilu Pharmaceutical has undertaken 41 major national science and technology projects targeted for the development of new drugs.
Tel: +86-531-83127705, 83127704, 83127706, 83127711
Address: 8888 Lvyou Road, High-tech Zone, Jinan, 250104, China